Skip to main content
Equibles
PHR logo

PHR · Phreesia, Inc.

Track PHR — free

Use PHR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$10.94 -0.16 (-1.44%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$679.06M
Shares
62.07M

PHR metrics

74 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$10.94
Market cap
$679.06M

Price action

19 metrics
Price change (1W)
-10.0%
Price change (30D)
-12.1%
Price change (3M)
+14.7%
Price change (6M)
-9.2%
Price change (YTD)
-35.3%
Price change (1Y)
-64.9%
Trailing year
Price change (5Y)
-83.7%
52-week high
$31.21
52-week low
$8.06
Change from 52-week high
-64.9%
Change from 52-week low
+35.7%
Annualized volatility
59.2%
Beta
0.4
RSI (14D)
41.2
Price vs SMA 50
-2.6%
Price vs SMA 200
-11.0%
Avg volume (3M)
892,433
Relative volume
0.9
Average dollar volume
$9.49M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
62.07M

Valuation

12 metrics
P / E (TTM)
60.8
Trailing earnings · reciprocal yield 1.6%
PEG ratio
0.3
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.3×
reciprocal yield 74.8%
P / book
1.8
reciprocal yield 54.8%
FCF yield
11.9%
TTM · current market cap
Buyback yield
—
P / FCF
8.4
reciprocal yield 11.9%
P / operating cash flow
7.4
reciprocal yield 13.5%
Earnings yield
1.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.7×
reciprocal yield 37.5%
EV / revenue historical average (5Y)
3.7×
reciprocal yield 27.4%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
182.7×
reciprocal yield 0.5%
EV / EBITDA historical average (5Y)
182.7×
reciprocal yield 0.5%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-09-02

Profitability

9 metrics
Gross margin
—
Operating margin
2.5%
Trailing 12 months
Net margin
2.1%
Gross profit (TTM)
—
Operating profit (TTM)
$12.54M
Net income (TTM)
$10.45M
Trailing 12 months
Diluted EPS (TTM)
$0.18
FCF margin
15.9%
Effective tax rate
-278.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-105.77

Growth

11 metrics
Revenue growth YoY
+10.4%
Year over year
Net income growth YoY
+193.3%
Revenue (TTM)
$507.79M
Trailing 12 months
EPS growth YoY
+200.0%
Shares change YoY
+1.3%
Year over year · more shares
Revenue CAGR (3Y)
+19.6%
Revenue CAGR (5Y)
+26.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
2.8%
Return on assets
1.6%
Debt / equity
—
Current ratio
1.8
EBITDA (TTM)
$49.65M
Free cash flow (TTM)
$80.75M
Quick ratio
1.8
Interest coverage
1.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$74.64M
Total assets
$646.98M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$91.38M
Capital expenditures (TTM)
$10.63M
R&D (TTM)
$116.28M
SG&A (TTM)
—
Stock compensation (TTM)
$59.43M
R&D / revenue
22.9%
Stock compensation / revenue
11.7%

Ownership (13F)

3 metrics
13F filers
229
13F filer change QoQ
-17
Institutional ownership
94.6%

Short interest

3 metrics
Short interest
4.4%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
50 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$58,477
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1412408 CUSIP 71944F106 13F (30d) 155 filings 154 filers Visit website Investor relations